Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174381 | 12717438 | 1 | I | 20160830 | 20160906 | 20160906 | EXP | US-JNJFOC-20160901505 | JANSSEN | STEPHENS DM, LI H, LEBLANC ML, PUVVADA SD, PERSKY D, FRIEDBERG JW, ET AL. CONTINUED RISK OF RELAPSE INDEPENDENT OF TREATMENT MODALITY IN LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: FINAL AND LONG-TERM ANALYSIS OF SOUTHWEST ONCOLOGY GROUP STUDY S8736.. JOURNAL OF CLINICAL ONCOLOGY 2016;34 (25):2997-3004. | 0.00 | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174381 | 12717438 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | U | 50718 | LIPOSOME INJECTION | ||||||||
| 127174381 | 12717438 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127174381 | 12717438 | 3 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127174381 | 12717438 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127174381 | 12717438 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127174381 | 12717438 | 1 | Diffuse large B-cell lymphoma |
| 127174381 | 12717438 | 2 | Diffuse large B-cell lymphoma |
| 127174381 | 12717438 | 3 | Diffuse large B-cell lymphoma |
| 127174381 | 12717438 | 4 | Diffuse large B-cell lymphoma |
| 127174381 | 12717438 | 5 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127174381 | 12717438 | DE |
| 127174381 | 12717438 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127174381 | 12717438 | Aortic aneurysm rupture | |
| 127174381 | 12717438 | Arrhythmia | |
| 127174381 | 12717438 | Cardiac failure congestive | |
| 127174381 | 12717438 | Cerebrovascular accident | |
| 127174381 | 12717438 | Infection | |
| 127174381 | 12717438 | Myocardial infarction | |
| 127174381 | 12717438 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |